NCT02597257

Efficacy and Safety of Lidocaine Infusion Treatment in Management of Neuropathic Pain

Efficacy and Safety of Lidocaine Infusion Treatment in Management of Neuropathic Pain: Randomized, Controlled, Comparative Study

• Status: Unknown
• Phase: Phase 2
• Study type: Interventional
• Enrollment: 44 (estimated)
• Sponsor: Seoul National University Hospital · Academic / Other
• Sex: All
• Age: 20 Years – 80 Years
• Healthy volunteers: Not accepted

Summary

The investigators conducted a randomized, Double blind, and Controlled Study to evaluate the Efficacy and safety of Lidocaine Infusion Treatment in Management of Neuropathic pain.

Detailed description

The investigators expect pain improvement after treatment with 3 mg/kg of lidocaine, continuously infused in normal saline 250 ml.

Conditions

• Postherpetic Neuralgia
• Diabetic Polyneuropathy
• Peripheral Neuropathy

Interventions

Type	Name	Description
DRUG	Lidocaine HCl	lidocaine continuous infusion
DRUG	Normal saline	Normal saline continuous infusion

Timeline

• Start date: 2015-08-01
• Primary completion: 2016-07-01
• Completion: 2016-07-01
• First posted: 2015-11-05
• Last updated: 2015-11-05

Locations

1 site across 1 country: South Korea